BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 27091625)

  • 1. Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway.
    Ruiz de Porras V; Bystrup S; Martínez-Cardús A; Pluvinet R; Sumoy L; Howells L; James MI; Iwuji C; Manzano JL; Layos L; Bugés C; Abad A; Martínez-Balibrea E
    Sci Rep; 2016 Apr; 6():24675. PubMed ID: 27091625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis.
    Wilson C; Purcell C; Seaton A; Oladipo O; Maxwell PJ; O'Sullivan JM; Wilson RH; Johnston PG; Waugh DJ
    J Pharmacol Exp Ther; 2008 Dec; 327(3):746-59. PubMed ID: 18780829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model.
    Kunnumakkara AB; Diagaradjane P; Anand P; Harikumar KB; Deorukhkar A; Gelovani J; Guha S; Krishnan S; Aggarwal BB
    Int J Cancer; 2009 Nov; 125(9):2187-97. PubMed ID: 19623659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell.
    Wang Z; Sun X; Feng Y; Wang Y; Zhang L; Wang Y; Fang Z; Azami NLB; Sun M; Li Q
    Phytomedicine; 2021 Feb; 82():153414. PubMed ID: 33461143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
    Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R
    Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GNA13 promotes tumor growth and angiogenesis by upregulating CXC chemokines via the NF-κB signaling pathway in colorectal cancer cells.
    Zhang Z; Tan X; Luo J; Cui B; Lei S; Si Z; Shen L; Yao H
    Cancer Med; 2018 Nov; 7(11):5611-5620. PubMed ID: 30267476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products.
    Kunnumakkara AB; Diagaradjane P; Guha S; Deorukhkar A; Shentu S; Aggarwal BB; Krishnan S
    Clin Cancer Res; 2008 Apr; 14(7):2128-36. PubMed ID: 18381954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
    Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel synthetic curcumin analogs as potent antiangiogenic agents in colorectal cancer.
    Rajitha B; Nagaraju GP; Shaib WL; Alese OB; Snyder JP; Shoji M; Pattnaik S; Alam A; El-Rayes BF
    Mol Carcinog; 2017 Jan; 56(1):288-299. PubMed ID: 27128654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of NF-κB translocation by curcumin analogs induces G0/G1 arrest and downregulates thymidylate synthase in colorectal cancer.
    Rajitha B; Belalcazar A; Nagaraju GP; Shaib WL; Snyder JP; Shoji M; Pattnaik S; Alam A; El-Rayes BF
    Cancer Lett; 2016 Apr; 373(2):227-33. PubMed ID: 26850372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways.
    Shakibaei M; Mobasheri A; Lueders C; Busch F; Shayan P; Goel A
    PLoS One; 2013; 8(2):e57218. PubMed ID: 23451189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin β-D-glucuronide exhibits anti-tumor effects on oxaliplatin-resistant colon cancer with less toxicity in vivo.
    Ozawa-Umeta H; Kishimoto A; Imaizumi A; Hashimoto T; Asakura T; Kakeya H; Kanai M
    Cancer Sci; 2020 May; 111(5):1785-1793. PubMed ID: 32163218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
    Cabrero-de Las Heras S; Martínez-Balibrea E
    World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest.
    Wang YT; Liu HS; Su CL
    Int J Food Sci Nutr; 2014 May; 65(3):368-74. PubMed ID: 24438326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex.
    Plummer SM; Holloway KA; Manson MM; Munks RJ; Kaptein A; Farrow S; Howells L
    Oncogene; 1999 Oct; 18(44):6013-20. PubMed ID: 10557090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy
    Sun C; Wang FJ; Zhang HG; Xu XZ; Jia RC; Yao L; Qiao PF
    World J Gastroenterol; 2017 Mar; 23(10):1816-1827. PubMed ID: 28348487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
    Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
    Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of NF-κB activation in the cisplatin resistance of human epidermoid carcinoma KCP-4 cells.
    Oiso S; Ikeda R; Nakamura K; Takeda Y; Akiyama S; Kariyazono H
    Oncol Rep; 2012 Jul; 28(1):27-32. PubMed ID: 22562377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer.
    Marquardt JU; Gomez-Quiroz L; Arreguin Camacho LO; Pinna F; Lee YH; Kitade M; Domínguez MP; Castven D; Breuhahn K; Conner EA; Galle PR; Andersen JB; Factor VM; Thorgeirsson SS
    J Hepatol; 2015 Sep; 63(3):661-9. PubMed ID: 25937435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism.
    Bava SV; Sreekanth CN; Thulasidasan AK; Anto NP; Cheriyan VT; Puliyappadamba VT; Menon SG; Ravichandran SD; Anto RJ
    Int J Biochem Cell Biol; 2011 Mar; 43(3):331-41. PubMed ID: 20883815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.